Skip to main content
Cancer Explained
Beginner 5 min readSource verified

What Is Randomization in a Clinical Trial?

A plain-language guide to how randomization works in cancer clinical trials and why it helps produce trustworthy, unbiased results.

AI-assisted and source verified. Not reviewed by a healthcare professional unless specifically stated.

Last updated: 2026-07-14Next planned review: 2027-07-14

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

Editorial status — Source verified. This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Our editorial processHow we use AIReport an error

NCI source

NCI last reviewed source: 2024-11-08

The short answer

Randomization is how researchers assign clinical trial participants by chance to different treatment groups, usually using a computer. It helps prevent bias so that results reflect the treatment itself rather than differences among the people receiving it. It's used mostly in later-phase trials.

  • Randomization means participants are assigned by chance to a trial group, usually by a computer.

  • In the simplest design, one group gets the study treatment and the other gets the standard treatment.

  • Randomization helps prevent bias that could make a new treatment look better or worse than it really is.

  • Neither you nor your doctor gets to choose which group you're placed in.

Choose how you want to understand this

The full explanation.

What randomization means

If you're thinking about joining a cancer clinical trial, you'll likely come across the word "randomization." It's the process researchers use to assign people by chance to different groups within a study, and it plays a big role in how later-phase trials are designed.

Rather than a doctor deciding who goes where, a computer program usually does the assigning. This might sound impersonal, but it's actually one of the ways researchers protect the integrity of a trial's results.

How the groups are set up

In the simplest version of a clinical trial, there are two groups:

  • The investigational group gets the study intervention or drug being tested.
  • The control group gets the standard treatment already used for that cancer.

Once you agree to join a randomized trial, you don't get to pick your group, and neither does your doctor. The assignment happens by chance.

Why researchers bother with this

The whole point of randomization is to prevent bias — a situation where results are shaped by human choices or other factors that have nothing to do with the treatment itself.

Here's a simple way to picture it. Suppose doctors were allowed to choose who went into which group. Even with good intentions, a doctor might lean toward placing patients who seem stronger or healthier into the group getting the new treatment, hoping to give them the best possible chance. Over the course of a trial, this kind of pattern would make the new treatment look more successful than it actually is, since the group receiving it started out in better shape to begin with.

Randomization spreads these kinds of differences evenly across both groups. When the study wraps up, researchers can be more confident that any difference in outcomes came from the treatment, not from who happened to end up where.

What to expect if you join

Agreeing to a randomized trial means accepting some uncertainty about which treatment you'll actually receive. That can feel like a big unknown, especially when you're already managing a cancer diagnosis. A few things may help put it in context:

  • The control group treatment is still a real, approved cancer treatment, not an absence of care.
  • You'll learn that a trial uses randomization during the informed consent process, well before you decide whether to join.
  • You're allowed to ask the study team exactly how the randomization works and what each group would receive before you agree to anything.

A common misconception

Some people worry that being randomized to the control group means missing out on care, or that being randomized to the investigational group means being a "test subject" without real oversight. Neither is quite right. Everyone in a randomized trial receives careful monitoring throughout the study, no matter which group they're in. The investigational group is testing something new, but always within a structured, closely watched process. The control group isn't left without treatment — it receives the same standard-of-care treatment a person might get outside the trial.

Not every trial uses it

Randomization isn't used in every phase of research. Early-phase trials, like phase 1 and many phase 2 studies, are often focused on finding a safe dose or checking for an early signal that a treatment might work. These trials may not involve randomly assigning participants to different groups at all. Randomization becomes standard mainly once researchers reach phase 3, where the goal is a head-to-head comparison between a new treatment and the current standard of care.

Bringing your questions to your care team

It's completely normal to want more detail about how a trial's design might affect you personally. If randomization is part of a trial you're considering, ask your care team or the study coordinator to walk you through it in plain terms. Understanding the process ahead of time can make the decision to join — or not join — feel more grounded.

Words to know

Tap any term to see what it means.

Browse the full glossary →

Common questions

What does randomization mean in a clinical trial?

It means participants are assigned by chance to different study groups, usually using a computer program, rather than being chosen by a doctor or the participant.

Why do researchers use randomization?

Randomization helps prevent bias — results being affected by human choices or factors unrelated to the treatment. For example, if doctors chose the groups themselves, they might unintentionally place healthier patients in the treatment group, making it look more effective than it is.

Can I choose which group I'm placed in?

No. Neither you nor your doctor can choose your group. Assignment happens by chance.

What does the control group receive?

In the simplest trial design, the control group receives the standard treatment already used for that cancer, while the investigational group receives the study drug or intervention being tested.

In which phase of trials is randomization most common?

Randomization is used mostly in later-phase trials, especially phase 3.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Quick quiz

Test your knowledge

0 of 4 answered

  1. Q1.According to this article, who or what usually assigns participants to a group in a randomized clinical trial?
  2. Q2.According to this article, in the simplest trial design, what does the control group receive?
  3. Q3.According to this article, why do researchers use randomization?
  4. Q4.According to this article, in which phase of clinical trials is randomization used mostly?

This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

Editorial status: Source verified This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.

Related learning map

How this explanation connects to 14 other things you can explore — related topics, terms, questions, practice, and its NCI source.

What Is Randomization in a Clinical Trial?